Biotech company Regeneron (NASDAQ:REGN) reported Q4 CY2024 results , with sales up 10.3% year on year to $3.79 billion. Its ...

Tim Bontemps and Brian Windhorst examine the latest Luka aftermath, where the Butler saga ends and why the league is ...

NBA trade season has suddenly become awash with landscape-altering activity. It's past time for the Golden State Warriors to ...